MIRA INFORM REPORT

Report Date :

19.09.2011

IDENTIFICATION DETAILS

Name :	FOCUS & RULZ PHARMACEUTICALS (PVT.) LIMITED

Registered Office :	Par Hoti, Mardan, N.W.F.P

Country :	Pakistan

Year of Establishment :	2004

Com. Reg. No.:	0047107

Legal Form :	Private Limited Company

Line of Business :	Manufacture & Marketing of Pharmaceutical Products

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory
Payment Behaviour :	Usually Correct
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2011

Country Name

Previous Rating

(31.12.2010)

Current Rating

(31.03.2011)

Pakistan

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Bottom of Form

Business Name

FOCUS & RULZ PHARMACEUTICALS (PVT.) LIMITED

Full Address

Registered Address & Factory

Par Hoti, Mardan, N.W.F.P., Pakistan

Tel #	92 (937) 560873, 560837
Fax #	92 (937) 560837
Email	fazals@brain.net.pk

Short Description Of Business

a.	Nature of Business	Manufacture & Marketing of Pharmaceutical Products
b.	Year Established	2004
c.	Registration #	0047107

Factory Location

Address	Plot # 44, Industrial Triangle, Area Kahuta Road, Islamabad, Pakistan
Tel #	92 (51) 4493174
Fax #	92 (51) 4493361

Auditors

Dilroze Khan & Co.

(Chartered Accountants)

1-B, ATS Centre, 30-West Fazal-Ul-Haq Road, Blue Area, Islamabad, Pakistan

Legal Status

Subject Company was established as a Private Limited Company in 2004

Authorized Capital	Rs. 10,000,000/-
Issued & Paid up Capital	Rs. 3,500,300/-

Details of Directors

Names

Nationality

Address

Occupation

Designation

Mr. Muhammad Atif

Mr. Fazli Khaliq Khan

Mr. Fazli Hanan

Pakistani

Pir Hoti, Mardan, N.W.F.P.

Business

Chief Executive

Director

Shareholders

Names

Mr. Muhammad Atif

Mr. Fazli Khaliq Khan

Mr. Fazli Hanan

Associates

A. Subsidiary

None

B. Associated Companies

(1) New Fazal Match Factory (Pvt) Limited, Pakistan.

(2) Original Traders, Pakistan.

Products

Manufacture & marketing of different pharmaceutical class like Anti Biotic, Anti Malarials, Anti-Rheumatic, Antihistamine, Narcotic Analgesic, Non Steroidal Respiratory Anti Inflamatory, Quinolones, Vitamins, Phenothiazine, Hypolipidaemics, Muscle Relaxant etc

Number of Employees

Annual Production Volume

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacturing.

Annual Sales Volume

Year	In Pak Rupees
2009	33,000,000/- (Estimated)

Trade Suppliers

(Foreign)

· AURINDO PHARMA, INDIA.

· INOGENT LABORATORIES (PVT) LIMITED, INDIA.

Distributors

Mainly exist at Punjab & N.W.F.P. Province

Bankers

· Habib Bank Limited, Pakistan.

· Al-Baraka Islamic Bank B.S.C., Pakistan.

· Standard Chartered Bank, Pakistan.

· Bank Alfalah Limited, Pakistan.

Memberships

· Rawalpindi Chamber of Commerce & Industry.(RCCI)

Foreign Exchange Rates

Currency	Unit	Pakistani Rupee
US Dollar	1	Rs. 88.55
UK Pound	1	Rs. 140.50
Euro	1	Rs. 122.50

Comments

Subject Company was established in 2004 and is engaged in manufacture & marketing of Pharmaceutical Products. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms and conditions.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.47.47
UK Pound	1	Rs.74.96
Euro	1	Rs.65.79

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.